CD8A and neoplasm: We also carried out depletion experiments to analyze the key immune cells involved in the combination therapy and discovered that CD8+ T cells played a predominant role in the response to the combination therapy and that macrophages and natural killer (NK) cells may be required for tumor regression (figure 1H–J).